Modulation of defensive behavior by periaqueductal gray NMDA/glycine-B receptor

Neuroscience and Biobehavioral Reviews

Volumn 25, Issue 7-8, 2001, Pages 697-709

  Carobrez, Antonio P ^a   Teixeira, Karina V ^a   Graeff, Frederico G ^b  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Anxiety; Blood pressure response; Defensive behavior; Electrical stimulation; Elevated plus maze; Excitatory amino acid; Fear; Glutamate; N methyl D aspartate glycine B receptor; Periaqueductal gray; Rats

Indexed keywords

2 AMINO 7 PHOSPHONOHEPTANOIC ACID; 3 (2 CARBOXY 2 PHENYLETHENYL) 4,6 DICHLORO 1H INDOLE 2 CARBOXYLIC ACID; 3 AMINO 1 HYDROXY 2 PYRROLIDINONE; 7 CHLORO 4 HYDROXY 3 (3 PHENOXYPHENYL) 2 QUINOLONE; AMINO ACID RECEPTOR; DIZOCILPINE; GLYCINE RECEPTOR; GLYCINE RECEPTOR AGONIST; MDL 102288; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR STIMULATING AGENT; RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ANXIETY; ARTICLE; BRAIN DEPTH STIMULATION; DEFENSIVE BEHAVIOR; FEAR; IMMUNOHISTOCHEMISTRY; MAZE TEST; NERVE CELL; NEUROMODULATION; NEUROTRANSMISSION; NONHUMAN; PANIC; PERIAQUEDUCTAL GRAY MATTER; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0035713222     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0149-7634(01)00059-8     Document Type: Review

References (167)

1. Toward a general psychobiological theory of emotions
2. Ethoexperimental approaches to the biology of emotion
3. Role of 5HT in defense behavior and anxiety
4. Proximate and evolutionary studies of anxiety, stress and depression: Synergy at the interface
5. Selection, evolution of behavior and animal models in behavioral neuroscience
6. Attack and defense in rodents as ethoexperimental models for the study of emotion
7. Behavioral correlates of chronic dominance-subordination relationships of male rats in a seminatural situation
8. Diazepam changes risk assessment in an anxiety/defense test battery
9. Brain mechanisms for offense, defense and submission
10. Minor tranquilizers and brain defense systems
11. Central representation of affective reaction in forebrain and brainstem: Electrical stimulation of amygdala, stria terminales and adjacent structures
12. Affektraktionen auf elektrishe reizung im hirnstamm der katze
13. Ways of viewing the central nervous control of the circulation - Old and new
14. Approach escape interactions in the rat brain
15. GABA modulation of the defense reaction induced by brain electrical stimulation
16. Introduction - Emerging principles of organization of the midbrain periadqueductal gray matter
17. Organization of the subcortical system governing defense and flight reaction in the cat
18. Stimulation of periaqueductal gray and hypothalamus
19. Role of the periaqueductal gray substance in the antianxiety action of benzodiazepines
20. Taming of wild Rattus norvegicus by lesions of the mesencephalic central gray
21. Brain mechanisms of aggression as revealed by electrical and chemical stimulation: Suggestion of a central role for the midbrain periaqueductal grey region
22. Ventral and dorsolateral regions of the midbrain periaqueductal gray (PAG) control different stages of defensive behavior: Dorsolateral PAG lesions enhance the defensive freezing produced by massed and immediate shock
23. Involvement of the dorsal periaqueductal gray in the loss of fear-potentiated startle accompanying high footshock training
24. Lesions of periaqueductal gray dissociate-conditioned freezing from conditioned suppression behavior in rats
25. Does long term potentiation in periaqueductal gray (PAG) mediate lasting changes in rodent anxiety-like behavior (ALB) produced by predator stress? Effects of low frequency stimulation (LFS) of PAG on place preference and changes in ALB produced by predator stress
26. Active muscle vasodilatation produced by stimulation of the brainstem: Its significance in the defense reaction
27. Periaqueductal gray
28. Columnar organization in the midbrain periaqueductal gray: Modules for emotional expression?
29. Functional characteristics of the midbrain periaqueductal gray
30. A search for brain stem cell groups integrating the defence reaction in the rat
31. Neuroeffector mechanisms of the defense reaction in the rat
32. Hippocampal projections and related neural pathways to the midbrain in the cat brain
33. The midbrain periaqueductal gray in the rat, cat, and monkey: A Nissl, Weil, and Golgi analysis
34. Surgery in the rat during electrical analgesia by focal brain stimulation
35. Sensation evoked by stimulation in the midbrain of man
36. Corticospinal control of striking in centrally elicited attack behavior
37. Enhancing GABAergic transmission reverses the aversive state in rats induced by electrical stimulation of the periaqueductal grey region
38. Aggressive behavior induced by electrical stimulation in the midbrain central gray of male rats
39. Which elements are excited in electrical stimulation of mammalian central nervous system: A review
40. A method for evoking physiological responses by stimulation of cell bodies, but not axons of passage, within localized regions of the central nervous system
41. Columnar organization in the midbrain periaqueductal gray and the integration of emotional expression
42. The midbrain periaqueductal gray in the rat. II. A golgi analysis
43. The defence-arousal system and its relevance for circulatory and respiratory control
44. Neurotransmitters in the dorsal periaqueductal gray and animal model of panic anxiety
45. The relation between fear induced by novelty stimulation and exploratory behavior
46. Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of fear-motivated behavior
47. The elevated plus-maze: Pharmacology, methodology and ethology
48. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat
49. The use of a plus-maze to measure anxiety in the mouse
50. An ethological analysis of the effects of chlordiazepoxide and bretazenil (Ro 16-6028) in the murine elevated plus-maze
51. Ethopharmacological analysis of rat behavior on the elevated plus-maze
52. 5-Hydroxytryptamine pathways in anxiety and its treatment
53. Anxiogenic stimuli in the elevated plus-maze
54. Previous maze experience required to increase open arms avoidance in rats submitted to the elevated plus-maze model of anxiety
55. Corticosterone response to the plus-maze: High correlation with risk assessment in rats and mice
56. Antinociceptive effects of elevated plus-maze exposure: Influence of opiate receptor manipulations
57. Induction of Fos immunoreactivity in the brain by exposure to the elevated plus-maze
58. Fos-like immunoreactivity in the periaqueductal gray of rats exposed to a natural predator
59. When a rat smells a cat: The distribution of Fos immunoreactivity in rat brain following exposure to a predatory odor
60. Central c-fos expression following 20 kHz/ultrasound induced defence behaviour in the rat
61. Elicitation and reduction of fear: Behavioural and neuroendocrine indices and brain induction of the immediate-early gene c-fos
62. Neuroanatomical targets of anxiogenic drugs in the hindbrain as revealed by Fos immunocytochemistry
63. Excitatory amino acid receptors in the vertebrate central nervous system
64. Regional and synaptic expression of ionotropic glutamate receptors
65. The glutamate receptor ion channels
66. Kinetic analysis of antagonist action at N-methyl-D-aspartic acid receptors. Two binding sites each for glutamate and glycine
67. Activation of metabotropic glutamate receptor 1 accelerates nmda receptor trafficking
68. Glycine potentiates the NMDA response in cultured mouse brain neurons
69. Requirement for glycine in activation of NMDA-receptor expressed in Xenopus oocyte
70. Glycine and N-methyl-D-aspartate receptors: Physiological significance and possible therapeutic applications
71. Glutamate uptake
72. Glycine uptake governs glycine site occupancy at NMDA receptor of excitatory synapses
73. Synaptic plasticity and learning: Selective impairment of learning in rats and blockade of long-term potentiation in vivo by N-methyl-D-aspartate receptor antagonist AP5
74. Excitatory amino acid neurotransmission: NMDA receptors and Hebb-type synaptic plasticity
75. Glycine antagonists for treatment of ischemic brain injury
76. Possible therapeutic applications of antagonists of excitatory amino acid neurotransmitters
77. D-Cycloserine enhances implicit memory in Alzheimer patients
78. Excitatory amino acid antagonist (kynurenic acid and MK-801) attenuate the development of morphine tolerance in the rat
79. Ethanol withdrawal is associated with increased extracellular glutamate in the rat striatum
80. Can patients with chronic neuropathic pain be cured by acute administration of the NMDA receptor antagonist amantadine?
81. Anxiolytic effect of glycine antagonists microinjected into the dorsal periaqueductal grey
82. Increased plasma serine concentrations in depression
83. Effects of phencyclidine and ketamine in pigeons on behavior suppressed by brief electrical shocks
84. Facilitatory effect of ketamine on punished behavior
85. Autoradiographic distribution of phencyclidine receptors in the rat brain using [3H]1-(1-(2-thienyl)cyclohexyl)piperidine ([3H]TCP)
86. 2-Amino-7-phosphonoheptanoic acid (AP7) produces discriminative stimuli and anticonflict effects similar to diazepam
87. Does the excitatory amino acid receptor antagonist 2-APH exhibit anxiolytic activity?
88. Effects of antagonists at the NMDA receptor complex in two models of anxiety
89. Effects of 5-HT1A receptor agonists and NMDA receptor antagonists in the social interaction test and the elevated plus maze
90. NMDA receptor complex antagonists have potential anxiolytic effects as measured with separation-induced ultrasonic vocalizations
91. Anxiolytic-like effects of N-methyl-D-aspartate-associated glycine receptor ligands in the rat potentiated startle test
92. Effects of HA-966 on conflict, social interaction, and plus-maze behaviors
93. Anxiolytic properties of 1-aminocyclopropancarbocylic acid, a ligand at strychnine insensitive glycine receptors
94. MDL-100,458 and MDL-102,288: Two potent and selective glycine receptor antagonists with different functional profiles
95. Induction of rage following microinjections of glutamate into midbrain but not hypothalamus of cats
96. Excitatory amino acid binding sites in the periaqueductal gray of the rat
97. Midbrain periaqueductal gray control of defensive behavior in the cat and the rat
98. Defensive behavior and hypertension induced by glutamate in the midbrain central gray of the rat
99. Cardiovascular components of the defence reaction evoked by excitation of neuronal cell bodies in the midbrain periaqueductal grey of the cat
100. Antagonism by L-glutamic acid diethyl ester (GDEE) of the defense reaction caused by microinjection of glutamate into the dorsal periaqueductal gray-matter of the rat
101. The antagonism of the glutamate-induced and synaptic excitations of thalamic neurones
102. The antagonism of amino acid-induced excitation of spinal neurones in the cat
103. Excitatory amino acids and the brain aversive system
104. An excitatory amino acid projection from ventromedial hypothalamus to periaqueductal gray in the rat: Autoradiographic and electrophysiological evidence
105. Role of NMDA receptors in hypothalamic facilitation of feline defensive rage elicited from the midbrain periaqueductal gray
106. Antagonism of non-NMDA receptors in the dorsal periaqueductal grey induces anxiolytic effect in the elevated plus maze
107. Characterization of pretentorial periaqueductal gray matter neurons mediating intraspecific defensive behaviors in the rat by microinjections of kainic acid
108. Expression and conditioned inhibition of fear-potentiated startle after stimulation and blockade of AMPA/kainate and GABA(A) receptors in the dorsal periaqueductal gray
109. Opposing roles of the amygdala and dorsolateral periaqueductal gray in fear-potentiated startle
110. Thresholds of electrically induced defence reaction of the rat: Short- and long-term adaptation mechanisms
111. Defense reaction induced by a metabotropic glutamate receptor agonist microinjected into the dorsal periaqueductal gray of rats
112. Intrinsic properties of lateral and dorsolateral columns of periaqueductal gray matter
113. Microinjection of D-2-amino-7-phosphonoheptanoate into the dorsal periaqueductal gray matter reduces the pressor response to glutamate injected at the same site
114. Anxiolytic effect in the elevated plus-maze of the NMDA receptor antagonist AP7 microinjected into the dorsal periaqueductal grey
115. NMDA receptors in the midbrain periaqueductal gray mediate hypothalamically evoked hissing behavior in the cat
116. The NMDA receptor: Central role in pain inhibition in rat periaqueductal gray
117. NMDA receptor blockade in the periaqueductal grey prevents stress-induced analgesia in attacked mice
118. MK-801 produces a reduction in anxiety-related antipredator defensiveness in male and female rats and a gender-dependent increase in locomotor behavior
119. Anxiolytic effect of kynurenic acid microinjected into the dorsal periaqueductal gray matter of rats placed in the elevated plus-maze test
120. Anxiogenic-like effect of glycine and D-serine microinjected into dorsal periaqueductal gray matter of rats
121. NMDA-coupled periaqueductal gray glycine receptors modulate anxioselective drug effects on plus-maze performance
122. Further localization of midbrain neurones mediating the defence reaction in the cat by microinjections of excitatory amino acids
123. Connections between the central nucleus of the amygdala and the midbrain periaqueductal gray: Topography and reciprocity
124. Reciprocal connections between the medial preoptic area and the midbrain periaqueductal gray in rat: A WGA-HRP and PHA-L study
125. Extensive projections from the midbrain periaqueductal gray to the caudal ventrolateral medulla: A retrograde and anterograde tracing study in the rat
126. Distribution of basal-expressed c-fos-like immunoreactive cells of the periaqueductal grey matter of the rat
127. Somatosensory contributions to c-fos activation within the caudal periaqueductal gray of lactating rats: Effects of perioral, rooting, and suckling stimuli from pups
128. Estrogen receptor-alpha-immunoreactive neurons in the periaqueductal gray of the adult ovariectomized female cat
129. Androgen and estrogen (alpha) receptor distribution in the periaqueductal gray of the male rat
130. Effects of glycine or (+/-)-3-amino-1-hydroxy-2-pyrrolidone microinjections along the rostrocaudal axis of the dorsal periaqueductal gray matter on rats' performance in the elevated plus-maze task
131. Pharmacological properties of recombinant human N-methyl-D-aspartate receptors comprising NR1a/NR2A and NR1a/NR2B subunit assemblies expressed in permanently transfected mouse fibroblast cells
132. Pharmacological heterogeneity of NMDA receptors: Characterization of NR1a/NR2D heteromers expressed in Xenopus oocytes
133. Glycine reverses antagonism of N-methyl-D-aspartate (NMDA) by 1-hydroxy-3-aminopyrrolidone-2 (HA-966) but not by D-2-amino-5-phosphonovalerate (D-AP5) on rat cortical slices
134. 7-Chlorokynurenic acid is a selective antagonist at the glycine modulatory site of the N-methyl-D-aspartate receptor complex
135. Desensitization of NMDA receptor channels is modulated by glutamate agonists
136. Molecular diversity of the NMDA receptor channel
137. D-serine as a neuromodulator: Regional and developmental localizations in rat brain glia resemble NMDA receptors
138. Modulation of N-methyl-D-aspartate receptor function by glycine transport
139. Regional distribution and developmental variation of the glycine transporters GLYT1 and GLYT2 in the rat CNS
140. Control of NMDA receptor activation by a glycine transporter co-expressed in Xenopus oocytes
141. Long-lasting inhibitory avoidance acquisition in rats submitted to the elevated T-maze model of anxiety
142. Influence of prior maze experience on behaviour and response to diazepam in the elevated plus-maze and light/dark tests of anxiety in mice
143. 5-HT and mechanisms of defence
144. Dorsal periaqueductal gray-induced aversion as a simulation of panic anxiety: Elements of face and predictive validity
145. Long-term effects of clomipramine and fluoxetine on dorsal periaqueductal grey-evoked innate defensive behaviours of the rat
146. AMPA, kainate and NMDA ionotropic glutamate receptor expression - An in situ hybridization atlas
147. Kindling of the midbrain periaqueductal gray in rats
148. Antidepressants for the new millennium
149. The N-methyl-D-aspartate receptor, synaptic plasticity, and depressive disorder. A critical review
150. Chronic treatment with antidepressants affects glycine/NMDA receptor function: Behavioral evidence
151. The effects of NMDA receptor antagonists and nitric oxide synthase inhibitors on opioid tolerance and withdrawal: Medication development issues for opiate addiction
152. R-(+)-HÁ-966, an antagonist for glycine NMDA receptor prevents locomotor sensitization to repeated cocaine exposures
153. Glutamate receptors in alcohol withdrawal-induced neurotoxicity
154. Infant rat separation is a sensitive test for novel anxiolytics
155. Effects of 5,7-dichlorokynurenic acid on conflict, social interaction and plus maze behaviors
156. The effects of periaqueductally injected transmitter antagonists on forebrain-elicited vocalization in the squirrel monkey
157. Differential effects of compounds that act at strychnine-insensitive glycine receptors in a punishment procedure
158. Anticonflict effects of a competitive NMDA receptor antagonist and a partial agonist at strychnine-insensitive glycine receptors
159. Pharmacological characterization of MDL-105,519, an NMDA receptor glycine site antagonist
160. D-cycloserine blocks the effects of ethanol and HA-966 in rats tested in the elevated plus-maze
161. Anxiolytic activity of glycine-B antagonists and partial agonists: No relation to intrinsic activity in the patch clamp
162. A characterization of anxiolytic like actions induced by the novel NMDA/glycine site antagonist, L-701,324